The role of risperidone in the treatment of children and adolescents with anorexia nervosa.

Jacopo PruccoliLuca BergonziniIlaria PettenuzzoAntonia Parmeggiani

Published in: Journal of psychopharmacology (Oxford, England) (2023)

This study reports real-life evidence of the use of risperidone in AN children and adolescents in the widest described sample so far. Longitudinal research should assess long-term prognostic factors and tolerability.

Keyphrases

prognostic factors
anorexia nervosa
open label
cross sectional
double blind
placebo controlled